Mark S. Forman
Chief Medical Officer · Ventyx Biosciences, Inc.
- 2025
- Mar 4, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark S. Forman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Raju Mohan - $365K in VTYX purchases and sales in the last 12 months
- John Nuss - $98K in VTYX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark S. Forman?
Mark S. Forman is a corporate insider, tracked as Chief Medical Officer of Ventyx Biosciences, Inc. (VTYX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Mark S. Forman last file a Form 4?
The most recent primary Form 4 on record is dated 4 March 2026, one of 2 filings going back to 2025.